LONDON, November 7, 2017 /PRNewswire/ --
Despite the World Health Organization (WHO) citing immunisation
(Photo: http://mma.prnewswire.com/media/598079/GSK_Vaccines_Parents.jpg )
(Photo: http://mma.prnewswire.com/media/598076/GSK_Vaccines_Grandparents.jpg )
(Photo: http://mma.prnewswire.com/media/598075/Overall_healthcare_professional_results_Infographic.jpg )
(Photo: http://mma.prnewswire.com/media/598074/Overall_general_public_results_Infographic.jpg )
Findings from the Vaccinate for Life survey of 6,002 adults aged 18 years and over, carried out across five countries also found that:
"Although mostly associated with childhood, vaccination is not something you outgrow," said Susanna Esposito, Full Professor at the University of Perugia, Italy, and infectious disease specialist. "As we age, so does our immune system and we become more susceptible to infectious diseases which could be prevented through vaccination. It is important that HCPs are aware of the possible benefits of adult vaccination and discuss it with their patients."
Findings from the Vaccinate for Life survey show that when asked to consider why they are not up-to-date, people cite lack of recommendations and/or discussion from their doctor or nurse about the need for vaccines in adult life. They say that they would find a range of information sources useful to help them understand, record and track the vaccinations which may be relevant to them.
"Vaccination throughout life can help protect and contribute to the wellbeing of individuals families and communities," said Dr. Thomas Breuer, Chief Medical Officer, GSK Vaccines. "What the Vaccinate for Life survey shows us is that adults need more information on the vaccines relevant to them to help them be more proactive in discussing their vaccination needs with their healthcare professional."
Other key findings from the Vaccinate for Life survey include:
Notes to Editors
About Vaccinate for Life
Vaccinate for Life is a global campaign to improve awareness of the importance of vaccination throughout life and encourage more conversations between healthcare professionals (HCPs) and their adult patients about what vaccinations may be available. To find out more about the Vaccinate for Life campaign, please visit gsk.to/vaccinateforlife.
About the Vaccinate for Life Survey
Vaccinate for Life General Public Survey
The 'Vaccinate for Life Survey' was carried out between July 6th and September 14th 2017 via an online survey of adults aged 18 years and over, with an achieved sample of 6,002 respondents, from five countries (Brazil, Germany, India, Italy and the United States). The sample size in each market was as follows:
Brazil Germany India Italy United States General Public 1000 1000 2002 1000 1000
Important note on sample definition by market
In four of the five markets (Brazil, Italy, Germany and the United States) the sample was collected according to the following sample specifications:
In India the sample was collected according to the following specifications:
In all markets a quota sampling approach was used.
The aggregate data at a five market (multi-country) level has been weighted to give each country an equal weight in the total and thus remove any bias caused by the sample being disproportionately larger in India versus the other 4 markets.
* Data for India is based on 6 cities only (Mumbai, Delhi, Bangalore, Kolkata, Chennai and Hyderabad)
** Question asked in India, United States, Germany and Italy
Vaccinate for Life HCP Survey
The 'Vaccinate for Life Survey' was carried out online between July 16thand August 25th 2017 with an achieved sample of 1,351 respondents, from across three countries (Brazil, Italy and the United States). The criteria for inclusion were that potential respondents must provide a current adult vaccination service, i.e. vaccines for people aged 18 years and over or advise on current adult vaccination services. They must also have between 3 and 30 years' experience as a practising HCP. The type of HCP selected to survey across the countries depended on the specialty responsible for adult vaccinations. An honorarium was offered to HCPs in all countries for participating. The sample composition in each market was as follows:
Brazil Italy United States PCPs 501 Pharmacists 500 GPs 100 100 Hygienists 50 Practice Nurses 50 Pulmonologists & 50 Obstetricians Total 200 150 1001
Important note on comparing total data/country differences
Variations in the sample composition across the three markets means that caution is needed when interpreting findings at a total level and drawing comparisons between countries, specifically those relating to current vaccination services and patient populations i.e. Q1A-Q1C and Q7. Caution also needs to be taken when interpreting the data shown at a total level and drawing conclusions due to the significantly larger sample of HCPs surveyed in the United States.
GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit http://www.gsk.com.
GSK Global Media Enquiries:
Sara Webber, +32(0)478-96-36-32
SOURCE GSK Vaccines
Subscribe to our Free Newsletters!
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...
Ear, nose and throat are important organs and disease in one area can affect the others. ENT ...
If you want to stop breastfeeding, then here is your guide to doing it the right way. Find the ...View All